GL1X · GenesisL1 explorer

Research workbench

Crystal structure of tr-alpha bound to T3 in a second site

Analyse Crystal structure of tr-alpha bound to T3 in a second site in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4LNW
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thyroid hormone receptor alpha
UniProt
P10827
Ligands
T3
Pockets
3 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 65% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThyroid hormone receptor alphaprotein26365% helix, 5% strandP10827

Ligands and binding sites

  • T3 · 3,5,3'triiodothyronine · ligand · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13130.800.9046T3
21310.440.7724empty
3580.330.7613empty

Modifications

Observed in the structure: 4 modified (artifact).

Compared structures

  • 4LNW · Crystal structure of TR-alpha bound to T3 in a second site · the same entry in another collection · chain A against A, TM-score 1.00
  • P10827 · AlphaFold monomer V2.0 prediction for thyroid hormone receptor alpha (P10827) · a predicted model of the same protein · chain A against A, TM-score 0.88

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.